Treatment of Intrabony Defects With Simvastatin and Antimicrobial Photodynamic Therapy
Primary Purpose
Simvastatin, Photodynamic Therapy, Periodontal Diseases
Status
Unknown status
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
SMV and antimicrobial photodynamic therapy
SMV application
Sponsored by
About this trial
This is an interventional treatment trial for Simvastatin
Eligibility Criteria
Inclusion Criteria:
- Patients were all healthy and free from any systemic disease;
- no history of antibiotic therapy or periodontal treatment for at least 6 months preceding the study;
- patients were willing and able to return for multiple follow-up visits;
- good levels of oral hygiene
Exclusion Criteria:
- Pregnant and lactating female patients,
- smokers,
- alcoholics,
- those receiving any medication that could affect healing of soft or hard tissue
Sites / Locations
- Faculty of Dentistry, Kafrelsheikh University
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
SMV and antimicrobial photodynamic therapy
SMV application
Arm Description
Application SMV and antimicrobial photodynamic therapy in intrabony defect
Application SMV in intrabony defect
Outcomes
Primary Outcome Measures
Clinical evaluation and measurements of the defect in millimeters
Changes in clinical measurements after application of simvastatin with and without antimicrobial photodynamic therapy in millimeters
Radiographic evaluation and measurements of the defect in millimeters
Changes in bone formation in millimeters after application of simvastatin with and without antimicrobial photodynamic therapy in millimeters
Secondary Outcome Measures
Full Information
NCT ID
NCT05031923
First Posted
August 20, 2021
Last Updated
August 26, 2021
Sponsor
Kafrelsheikh University
1. Study Identification
Unique Protocol Identification Number
NCT05031923
Brief Title
Treatment of Intrabony Defects With Simvastatin and Antimicrobial Photodynamic Therapy
Official Title
Treatment of Intrabony Defects With Simvastatin and Antimicrobial Photodynamic Therapy: A Randomized Controlled Clinical Trial
Study Type
Interventional
2. Study Status
Record Verification Date
August 2021
Overall Recruitment Status
Unknown status
Study Start Date
October 2021 (Anticipated)
Primary Completion Date
August 2022 (Anticipated)
Study Completion Date
August 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Kafrelsheikh University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
Antimicrobial photodynamic therapy (aPDT) is characterized by the association of photosensitizing agents, promoting the generation of reactive oxygen species like free radicals and singlet oxygen, which are cytotoxic to certain bacteria. Simvastatin (SMV) enhances alkaline phosphatase activity and increases the expression of bone sialoprotein, osteocalcin, and type I collagen and is shown to have an anti-inflammatory effect by decreasing the production of C-reactive protein (CRP), IL-6, and IL-8. SMV is also reported to stimulate VEGF release in a dose-dependent manner which promotes osteoblast differentiation and bone nodule formation. The aim of this study is to evaluate the adjunctive effects of SMV with and without aPDT in chronic periodontitis patients.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Simvastatin, Photodynamic Therapy, Periodontal Diseases
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
20 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
SMV and antimicrobial photodynamic therapy
Arm Type
Experimental
Arm Description
Application SMV and antimicrobial photodynamic therapy in intrabony defect
Arm Title
SMV application
Arm Type
Active Comparator
Arm Description
Application SMV in intrabony defect
Intervention Type
Procedure
Intervention Name(s)
SMV and antimicrobial photodynamic therapy
Intervention Description
Application of SMV and antimicrobial photodynamic therapy in intrabony defects
Intervention Type
Procedure
Intervention Name(s)
SMV application
Intervention Description
Application of SMV without antimicrobial photodynamic therapy in intrabony defects
Primary Outcome Measure Information:
Title
Clinical evaluation and measurements of the defect in millimeters
Description
Changes in clinical measurements after application of simvastatin with and without antimicrobial photodynamic therapy in millimeters
Time Frame
9 months
Title
Radiographic evaluation and measurements of the defect in millimeters
Description
Changes in bone formation in millimeters after application of simvastatin with and without antimicrobial photodynamic therapy in millimeters
Time Frame
9 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Patients were all healthy and free from any systemic disease;
no history of antibiotic therapy or periodontal treatment for at least 6 months preceding the study;
patients were willing and able to return for multiple follow-up visits;
good levels of oral hygiene
Exclusion Criteria:
Pregnant and lactating female patients,
smokers,
alcoholics,
those receiving any medication that could affect healing of soft or hard tissue
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Dalia R Issa, PhD
Phone
01007753636
Ext
002
Email
dalia_rasheed@hotmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Dalia R Issa, PhD
Organizational Affiliation
Kafrelsheikh University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Faculty of Dentistry, Kafrelsheikh University
City
Kafr Ash Shaykh
ZIP/Postal Code
33511
Country
Egypt
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Dalia R Issa, PhD
Phone
01007753636
Ext
002
Email
dalia_rasheed@hotmail.com
12. IPD Sharing Statement
Learn more about this trial
Treatment of Intrabony Defects With Simvastatin and Antimicrobial Photodynamic Therapy
We'll reach out to this number within 24 hrs